Carbotoxicity—Noxious Effects of Carbohydrates

Cell

Volumn 175, Issue 3, 2018, Pages 605-614

  Kroemer, Guido ^{a,b,c,d,e,f,g}   López Otín, Carlos ^h,i   Madeo, Frank ^j,k   de Cabo, Rafael ^l  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c INSERM   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^h DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

ⁱ Instituto Carlos III   (Spain)

^j UNIVERSITY OF GRAZ   (Austria)

^k BIOTECHMED GRAZ   (Austria)

^l NATIONAL INSTITUTES OF HEALTH   (United States)

more..

Author keywords

aging; diabetes; diet; health; longevity; metabolism; nutrition; obesity; restriction; sugar

Indexed keywords

ACARBOSE; CARBOHYDRATE; DAPAGLIFLOZIN; GLUCOSAMINE; GLUCOSE; LUTEOLIN; METFORMIN; SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR;

ACUTE KIDNEY FAILURE; CARBOHYDRATE INTAKE; CARBOHYDRATE METABOLISM; CARBOTOXICITY; DIABETES MELLITUS; DRUG MECHANISM; EPIDEMIOLOGICAL DATA; GLUCOSE METABOLISM; HUMAN; KETOGENESIS; KETOGENIC DIET; LOW CARBOHYDRATE DIET; MEDICAL HISTORY; MOLECULAR MECHANICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITION; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; TOXICITY;

EID: 85054562147     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2018.07.044     Document Type: Review

References (96)

1. Andres-Hernando, A., Li, N., Cicerchi, C., Inaba, S., Chen, W., Roncal-Jimenez, C., Le, M.T., Wempe, M.F., Milagres, T., Ishimoto, T., et al. Protective role of fructokinase blockade in the pathogenesis of acute kidney injury in mice. Nat. Commun., 8, 2017, 14181.
2. Bantug, G.R., Galluzzi, L., Kroemer, G., Hess, C., The spectrum of T cell metabolism in health and disease. Nat. Rev. Immunol. 18 (2018), 19–34.
3. Barrington, W.T., Wulfridge, P., Wells, A.E., Rojas, C.M., Howe, S.Y.F., Perry, A., Hua, K., Pellizzon, M.A., Hansen, K.D., Voy, B.H., et al. Improving metabolic health through precision dietetics in mice. Genetics 208 (2018), 399–417.
4. Beisswenger, P.J., Howell, S.K., Touchette, A.D., Lal, S., Szwergold, B.S., Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes 48 (1999), 198–202.
5. Bell, G.A., Kantor, E.D., Lampe, J.W., Shen, D.D., White, E., Use of glucosamine and chondroitin in relation to mortality. Eur. J. Epidemiol. 27 (2012), 593–603.
6. Bergheim, I., Weber, S., Vos, M., Krämer, S., Volynets, V., Kaserouni, S., McClain, C.J., Bischoff, S.C., Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J. Hepatol. 48 (2008), 983–992.
7. Birkeland, K.I., Jørgensen, M.E., Carstensen, B., Persson, F., Gulseth, H.L., Thuresson, M., Fenici, P., Nathanson, D., Nyström, T., Eriksson, J.W., et al. Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis. Lancet Diabetes Endocrinol. 5 (2017), 709–717.
8. Brewer, R.A., Gibbs, V.K., Smith, D.L. Jr., Targeting glucose metabolism for healthy aging. Nutr. Healthy Aging 4 (2016), 31–46.
9. Brown-Borg, H.M., Disentangling high fat, low carb, and healthy aging. Cell Metab. 26 (2017), 458–459.
10. Caminhotto, R.O., Komino, A.C.M., de Fatima Silva, F., Andreotti, S., Sertié R.A.L., Boltes Reis, G., Lima, F.B., Oral β-hydroxybutyrate increases ketonemia, decreases visceral adipocyte volume and improves serum lipid profile in Wistar rats. Nutr. Metab. (Lond.), 14, 2017, 31.
11. Carter, A., Hendrikse, J., Lee, N., Yücel, M., Verdejo-Garcia, A., Andrews, Z.B., Hall, W., The Neurobiology of “food addiction” and its implications for obesity treatment and policy. Annu. Rev. Nutr. 36 (2016), 105–128.
12. Celotto, A.M., Frank, A.C., Seigle, J.L., Palladino, M.J., Drosophila model of human inherited triosephosphate isomerase deficiency glycolytic enzymopathy. Genetics 174 (2006), 1237–1246.
13. Chia, C.W., Shardell, M., Tanaka, T., Liu, D.D., Gravenstein, K.S., Simonsick, E.M., Egan, J.M., Ferrucci, L., Chronic low-calorie sweetener use and risk of abdominal obesity among older adults: a cohort study. PLoS ONE, 11, 2016, e0167241.
14. Chiu, C.J., Milton, R.C., Klein, R., Gensler, G., Taylor, A., Dietary carbohydrate and the progression of age-related macular degeneration: a prospective study from the Age-Related Eye Disease Study. Am. J. Clin. Nutr. 86 (2007), 1210–1218.
15. Chiu, S., Mulligan, K., Schwarz, J.M., Dietary carbohydrates and fatty liver disease: de novo lipogenesis. Curr. Opin. Clin. Nutr. Metab. Care 21 (2018), 277–282.
16. Choi, J.M., Seo, M.H., Kyeong, H.H., Kim, E., Kim, H.S., Molecular basis for the role of glucokinase regulatory protein as the allosteric switch for glucokinase. Proc. Natl. Acad. Sci. USA 110 (2013), 10171–10176.
17. Dehghan, M., Mente, A., Zhang, X., Swaminathan, S., Li, W., Mohan, V., Iqbal, R., Kumar, R., Wentzel-Viljoen, E., Rosengren, A., et al., Prospective Urban Rural Epidemiology (PURE) study investigators. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. Lancet 390 (2017), 2050–2062.
18. Di Lorenzo, C., Coppola, G., Di Lenola, D., Evangelista, M., Sirianni, G., Rossi, P., Di Lorenzo, G., Serrao, M., Pierelli, F., Efficacy of modified Atkins ketogenic diet in chronic cluster headache: an open-label, single-arm, clinical trial. Front. Neurol., 9, 2018, 64.
19. Di Pino, A., Currenti, W., Urbano, F., Mantegna, C., Purrazzo, G., Piro, S., Purrello, F., Rabuazzo, A.M., Low advanced glycation end product diet improves the lipid and inflammatory profiles of prediabetic subjects. J. Clin. Lipidol. 10 (2016), 1098–1108.
20. Elia, M., Klepper, J., Leiendecker, B., Hartmann, H., Ketogenic diets in the treatment of epilepsy. Curr. Pharm. Des. 23 (2017), 5691–5701.
21. Fiolet, T., Srour, B., Sellem, L., Kesse-Guyot, E., Allès, B., Méjean, C., Deschasaux, M., Fassier, P., Latino-Martel, P., Beslay, M., et al. Consumption of ultra-processed foods and cancer risk: results from NutriNet-Santé prospective cohort. BMJ, 360, 2018, k322.
22. Forshaw, R., Dental indicators of ancient dietary patterns: dental analysis in archaeology. Br. Dent. J. 216 (2014), 529–535.
23. Frimat, M., Daroux, M., Litke, R., Nevière, R., Tessier, F.J., Boulanger, E., Kidney, heart and brain: three organs targeted by ageing and glycation. Clin. Sci. (Lond.) 131 (2017), 1069–1092.
24. Gelino, S., Chang, J.T., Kumsta, C., She, X., Davis, A., Nguyen, C., Panowski, S., Hansen, M., Intestinal autophagy improves healthspan and longevity in C. elegans during dietary restriction. PLoS Genet., 12, 2016, e1006135.
25. Gnerer, J.P., Kreber, R.A., Ganetzky, B., wasted away, a Drosophila mutation in triosephosphate isomerase, causes paralysis, neurodegeneration, and early death. Proc. Natl. Acad. Sci. USA 103 (2006), 14987–14993.
26. Gu, Y., Wang, X., Li, J., Zhang, Y., Zhong, H., Liu, R., Zhang, D., Feng, Q., Xie, X., Hong, J., et al. Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment. Nat. Commun., 8, 2017, 1785.
27. Gupta, P., Bala, M., Gupta, S., Dua, A., Dabur, R., Injeti, E., Mittal, A., Efficacy and risk profile of anti-diabetic therapies: Conventional vs traditional drugs-A mechanistic revisit to understand their mode of action. Pharmacol. Res. 113:Pt A (2016), 636–674.
28. Hadj Ahmed, S., Kharroubi, W., Kaoubaa, N., Zarrouk, A., Batbout, F., Gamra, H., Najjar, M.F., Lizard, G., Hininger-Favier, I., Hammami, M., Correlation of trans fatty acids with the severity of coronary artery disease lesions. Lipids Health Dis., 17, 2018, 52.
29. Harrison, D.E., Strong, R., Allison, D.B., Ames, B.N., Astle, C.M., Atamna, H., Fernandez, E., Flurkey, K., Javors, M.A., Nadon, N.L., et al. Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males. Aging Cell 13 (2014), 273–282.
30. Hannou, S.A., Haslam, D.E., McKeown, N.M., Herman, M.A., Fructose metabolism and metabolic disease. J. Clin. Invest. 128 (2018), 545–555.
31. Heussinger, N., Della Marina, A., Beyerlein, A., Leiendecker, B., Hermann-Alves, S., Dalla Pozza, R., Klepper, J., 10 patients, 10 years - long term follow-up of cardiovascular risk factors in Glut1 deficiency treated with ketogenic diet therapies: a prospective, multicenter case series. Clin. Nutr., 2017, 10.1016/j.clnu.2017.11.001 Published online November 11, 2017.
32. Hu, Y., Costenbader, K.H., Gao, X., Al-Daabil, M., Sparks, J.A., Solomon, D.H., Hu, F.B., Karlson, E.W., Lu, B., Sugar-sweetened soda consumption and risk of developing rheumatoid arthritis in women. Am. J. Clin. Nutr. 100 (2014), 959–967.
33. Ishimoto, T., Lanaspa, M.A., Rivard, C.J., Roncal-Jimenez, C.A., Orlicky, D.J., Cicerchi, C., McMahan, R.H., Abdelmalek, M.F., Rosen, H.R., Jackman, M.R., et al. High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase. Hepatology 58 (2013), 1632–1643.
34. Jameel, F., Phang, M., Wood, L.G., Garg, M.L., Acute effects of feeding fructose, glucose and sucrose on blood lipid levels and systemic inflammation. Lipids Health Dis., 13, 2014, 195.
35. Jang, S., Dilger, R.N., Johnson, R.W., Luteolin inhibits microglia and alters hippocampal-dependent spatial working memory in aged mice. J. Nutr. 140 (2010), 1892–1898.
36. Jang, C., Hui, S., Lu, W., Cowan, A.J., Morscher, R.J., Lee, G., Liu, W., Tesz, G.J., Birnbaum, M.J., Rabinowitz, J.D., The small intestine converts dietary fructose into glucose and organic acids. Cell Metab. 27 (2018), 351–361.
37. Jenkins, D.J., Wolever, T.M., Taylor, R.H., Barker, H., Fielden, H., Baldwin, J.M., Bowling, A.C., Newman, H.C., Jenkins, A.L., Goff, D.V., Glycemic index of foods: a physiological basis for carbohydrate exchange. Am. J. Clin. Nutr. 34 (1981), 362–366.
38. Jensen, T., Abdelmalek, M.F., Sullivan, S., Nadeau, K.J., Green, M., Roncal, C., Nakagawa, T., Kuwabara, M., Sato, Y., Kang, D.H., et al. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. J. Hepatol. 68 (2018), 1063–1075.
39. Johnson, R.J., Segal, M.S., Sautin, Y., Nakagawa, T., Feig, D.I., Kang, D.H., Gersch, M.S., Benner, S., Sánchez-Lozada, L.G., Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am. J. Clin. Nutr. 86 (2007), 899–906.
40. Johnson, R.J., Perez-Pozo, S.E., Sautin, Y.Y., Manitius, J., Sanchez-Lozada, L.G., Feig, D.I., Shafiu, M., Segal, M., Glassock, R.J., Shimada, M., et al. Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?. Endocr. Rev. 30 (2009), 96–116.
41. Johnson, R.J., Sánchez-Lozada, L.G., Andrews, P., Lanaspa, M.A., Perspective: a historical and scientific perspective of sugar and its relation with obesity and diabetes. Adv. Nutr. 8 (2017), 412–422.
42. Kender, Z., Fleming, T., Kopf, S., Torzsa, P., Grolmusz, V., Herzig, S., Schleicher, E., Rácz, K., Reismann, P., Nawroth, P.P., Effect of metformin on methylglyoxal metabolism in patients with type 2 diabetes. Exp. Clin. Endocrinol. Diabetes 122 (2014), 316–319.
43. Lanaspa, M.A., Sanchez-Lozada, L.G., Choi, Y.J., Cicerchi, C., Kanbay, M., Roncal-Jimenez, C.A., Ishimoto, T., Li, N., Marek, G., Duranay, M., et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J. Biol. Chem. 287 (2012), 40732–40744.
44. Lanaspa, M.A., Sanchez-Lozada, L.G., Cicerchi, C., Li, N., Roncal-Jimenez, C.A., Ishimoto, T., Le, M., Garcia, G.E., Thomas, J.B., Rivard, C.J., et al. Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver. PLoS ONE, 7, 2012, e47948.
45. Lanaspa, M.A., Ishimoto, T., Li, N., Cicerchi, C., Orlicky, D.J., Ruzycki, P., Rivard, C., Inaba, S., Roncal-Jimenez, C.A., Bales, E.S., et al. Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome. Nat. Commun., 4, 2013, 2434.
46. Lanaspa, M.A., Ishimoto, T., Cicerchi, C., Tamura, Y., Roncal-Jimenez, C.A., Chen, W., Tanabe, K., Andres-Hernando, A., Orlicky, D.J., Finol, E., et al. Endogenous fructose production and fructokinase activation mediate renal injury in diabetic nephropathy. J. Am. Soc. Nephrol. 25 (2014), 2526–2538.
47. Lanaspa, M.A., Kuwabara, M., Andres-Hernando, A., Li, N., Cicerchi, C., Jensen, T., Orlicky, D.J., Roncal-Jimenez, C.A., Ishimoto, T., Nakagawa, T., et al. High salt intake causes leptin resistance and obesity in mice by stimulating endogenous fructose production and metabolism. Proc. Natl. Acad. Sci. USA 115 (2018), 3138–3143.
48. Lee, S., Zhang, C., Kilicarslan, M., Piening, B.D., Bjornson, E., Hallström, B.M., Groen, A.K., Ferrannini, E., Laakso, M., Snyder, M., et al. Integrated network analysis reveals an association between plasma mannose levels and insulin resistance. Cell Metab. 24 (2016), 172–184.
49. Lim, J.S., Mietus-Snyder, M., Valente, A., Schwarz, J.M., Lustig, R.H., The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat. Rev. Gastroenterol. Hepatol. 7 (2010), 251–264.
50. Longo, V.D., Panda, S., Fasting, circadian rhythms, and time-restricted feeding in healthy lifespan. Cell Metab. 23 (2016), 1048–1059.
51. Luo, S., Monterosso, J.R., Sarpelleh, K., Page, K.A., Differential effects of fructose versus glucose on brain and appetitive responses to food cues and decisions for food rewards. Proc. Natl. Acad. Sci. USA 112 (2015), 6509–6514.
52. Lyssiotis, C.A., Cantley, L.C., Metabolic syndrome: F stands for fructose and fat. Nature 502 (2013), 181–182.
53. Madeo, F., Eisenberg, T., Pietrocola, F., Kroemer, G., Spermidine in health and disease. Science, 359, 2018, eaan2788.
54. Madiraju, A.K., Erion, D.M., Rahimi, Y., Zhang, X.M., Braddock, D.T., Albright, R.A., Prigaro, B.J., Wood, J.L., Bhanot, S., MacDonald, M.J., et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510 (2014), 542–546.
55. Maersk, M., Belza, A., Stødkilde-Jørgensen, H., Ringgaard, S., Chabanova, E., Thomsen, H., Pedersen, S.B., Astrup, A., Richelsen, B., Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am. J. Clin. Nutr. 95 (2012), 283–289.
56. Mardinoglu, A., Stančáková A., Lotta, L.A., Kuusisto, J., Boren, J., Blüher, M., Wareham, N.J., Ferrannini, E., Groop, P.H., Laakso, M., et al. Plasma mannose levels are associated with incident type 2 diabetes and cardiovascular disease. Cell Metab. 26 (2017), 281–283.
57. Mardinoglu, A., Wu, H., Bjornson, E., Zhang, C., Hakkarainen, A., Rasanen, S.M., Lee, S., Mancina, R.M., Bergentall, M., Pietilainen, K.H., et al. An integrated understanding of the rapid metabolic benefits of a carbohydrate-restricted diet on hepatic steatosis in humans. Cell Metab. 27 (2018), 559–571.
58. McSwiney, F.T., Wardrop, B., Hyde, P.N., Lafountain, R.A., Volek, J.S., Doyle, L., Keto-adaptation enhances exercise performance and body composition responses to training in endurance athletes. Metabolism 81 (2018), 25–34.
59. Mirtschink, P., Krishnan, J., Grimm, F., Sarre, A., Hörl, M., Kayikci, M., Fankhauser, N., Christinat, Y., Cortijo, C., Feehan, O., et al. HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease. Nature 522 (2015), 444–449.
60. Missios, P., Zhou, Y., Guachalla, L.M., von Figura, G., Wegner, A., Chakkarappan, S.R., Binz, T., Gompf, A., Hartleben, G., Burkhalter, M.D., et al. Glucose substitution prolongs maintenance of energy homeostasis and lifespan of telomere dysfunctional mice. Nat. Commun., 5, 2014, 4924.
61. Navarro, S.L., White, E., Kantor, E.D., Zhang, Y., Rho, J., Song, X., Milne, G.L., Lampe, P.D., Lampe, J.W., Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans. PLoS ONE, 10, 2015, e0117534.
62. Newman, J.C., Covarrubias, A.J., Zhao, M., Yu, X., Gut, P., Ng, C.P., Huang, Y., Haldar, S., Verdin, E., Ketogenic diet reduces midlife mortality and improves memory in aging mice. Cell Metab. 26 (2017), 547–557.
63. Offermanns, S., Hydroxy-carboxylic acid receptor actions in metabolism. Trends Endocrinol. Metab. 28 (2017), 227–236.
64. Oppelt, S.A., Zhang, W., Tolan, D.R., Specific regions of the brain are capable of fructose metabolism. Brain Res. 1657 (2017), 312–322.
65. Page, K.A., Chan, O., Arora, J., Belfort-Deaguiar, R., Dzuira, J., Roehmholdt, B., Cline, G.W., Naik, S., Sinha, R., Constable, R.T., Sherwin, R.S., Effects of fructose vs glucose on regional cerebral blood flow in brain regions involved with appetite and reward pathways. JAMA 309 (2013), 63–70.
66. Pepino, M.Y., Metabolic effects of non-nutritive sweeteners. Physiol. Behav. 152:Pt B (2015), 450–455.
67. Pietrocola, F., Galluzzi, L., Bravo-San Pedro, J.M., Madeo, F., Kroemer, G., Acetyl coenzyme A: a central metabolite and second messenger. Cell Metab. 21 (2015), 805–821.
68. Rendeiro, C., Masnik, A.M., Mun, J.G., Du, K., Clark, D., Dilger, R.N., Dilger, A.C., Rhodes, J.S., Fructose decreases physical activity and increases body fat without affecting hippocampal neurogenesis and learning relative to an isocaloric glucose diet. Sci. Rep., 5, 2015, 9589.
69. Roberts, M.N., Wallace, M.A., Tomilov, A.A., Zhou, Z., Marcotte, G.R., Tran, D., Perez, G., Gutierrez-Casado, E., Koike, S., Knotts, T.A., et al. A ketogenic diet extends longevity and healthspan in adult mice. Cell Metab. 26 (2017), 539–546.
70. Roncal-Jimenez, C.A., Ishimoto, T., Lanaspa, M.A., Milagres, T., Hernando, A.A., Jensen, T., Miyazaki, M., Doke, T., Hayasaki, T., Nakagawa, T., et al. Aging-associated renal disease in mice is fructokinase dependent. Am. J. Physiol. Renal Physiol. 311 (2016), F722–F730.
71. Rubio-Patino, C., Bossowski, J.P., De Donatis, G.M., Mondragon, L., Villa, E., Aira, L.E., Chiche, J., Mhaidly, R., Lebeaupin, C., Marchetti, S., et al. Low-protein diet induces IRE1alpha-dependent anticancer immunosurveillance. Cell Metab. 27 (2018), 828–842.
72. Sainsbury, E., Kizirian, N.V., Partridge, S.R., Gill, T., Colagiuri, S., Gibson, A.A., Effect of dietary carbohydrate restriction on glycemic control in adults with diabetes: a systematic review and meta-analysis. Diabetes Res. Clin. Pract. 139 (2018), 239–252.
73. Saslow, L.R., Daubenmier, J.J., Moskowitz, J.T., Kim, S., Murphy, E.J., Phinney, S.D., Ploutz-Snyder, R., Goldman, V., Cox, R.M., Mason, A.E., et al. Twelve-month outcomes of a randomized trial of a moderate-carbohydrate versus very low-carbohydrate diet in overweight adults with type 2 diabetes mellitus or prediabetes. Nutr. Diabetes, 7, 2017, 304.
74. Sharma, S.P., Chung, H.J., Kim, H.J., Hong, S.T., Paradoxical effects of fruit on obesity. Nutrients, 8, 2016 E633.
75. Si, J., Wang, S., Liu, N., Yang, X., Wang, Y., Li, L., Wang, J., Lv, X., Anticonvulsant effect of exogenous β-hydroxybutyrate on kainic acid-induced epilepsy. Exp. Ther. Med. 14 (2017), 765–770.
76. Siegel, K.R., Echouffo-Tcheugui, J.B., Ali, M.K., Mehta, N.K., Narayan, K.M., Chetty, V., Societal correlates of diabetes prevalence: an analysis across 94 countries. Diabetes Res. Clin. Pract. 96 (2012), 76–83.
77. Softic, S., Gupta, M.K., Wang, G.X., Fujisaka, S., O'Neill, B.T., Rao, T.N., Willoughby, J., Harbison, C., Fitzgerald, K., Ilkayeva, O., et al. Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling. J. Clin. Invest. 127 (2017), 4059–4074.
78. Solon-Biet, S.M., Walters, K.A., Simanainen, U.K., McMahon, A.C., Ruohonen, K., Ballard, J.W., Raubenheimer, D., Handelsman, D.J., Le Couteur, D.G., Simpson, S.J., Macronutrient balance, reproductive function, and lifespan in aging mice. Proc. Natl. Acad. Sci. USA 112 (2015), 3481–3486.
79. Stanhope, K.L., Schwarz, J.M., Keim, N.L., Griffen, S.C., Bremer, A.A., Graham, J.L., Hatcher, B., Cox, C.L., Dyachenko, A., Zhang, W., et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Invest. 119 (2009), 1322–1334.
80. Ströhle, A., Hahn, A., Diets of modern hunter-gatherers vary substantially in their carbohydrate content depending on ecoenvironments: results from an ethnographic analysis. Nutr. Res. 31 (2011), 429–435.
81. Te Morenga, L.A., Howatson, A.J., Jones, R.M., Mann, J., Dietary sugars and cardiometabolic risk: systematic review and meta-analyses of randomized controlled trials of the effects on blood pressure and lipids. Am. J. Clin. Nutr. 100 (2014), 65–79.
82. Tognini, P., Murakami, M., Liu, Y., Eckel-Mahan, K.L., Newman, J.C., Verdin, E., Baldi, P., Sassone-Corsi, P., Distinct circadian signatures in liver and gut clocks revealed by ketogenic diet. Cell Metab. 26 (2017), 523–538.
83. Veronese, N., Solmi, M., Caruso, M.G., Giannelli, G., Osella, A.R., Evangelou, E., Maggi, S., Fontana, L., Stubbs, B., Tzoulaki, I., Dietary fiber and health outcomes: an umbrella review of systematic reviews and meta-analyses. Am. J. Clin. Nutr. 107 (2018), 436–444.
84. Vlassara, H., Cai, W., Tripp, E., Pyzik, R., Yee, K., Goldberg, L., Tansman, L., Chen, X., Mani, V., Fayad, Z.A., et al. Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial. Diabetologia 59 (2016), 2181–2192.
85. Volkow, N.D., Wang, G.J., Telang, F., Fowler, J.S., Thanos, P.K., Logan, J., Alexoff, D., Ding, Y.S., Wong, C., Ma, Y., Pradhan, K., Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. Neuroimage 42 (2008), 1537–1543.
86. Wang, A., Huen, S.C., Luan, H.H., Yu, S., Zhang, C., Gallezot, J.D., Booth, C.J., Medzhitov, R., Opposing effects of fasting metabolism on tissue tolerance in bacterial and viral inflammation. Cell 166 (2016), 1512–1525.
87. Wang, Q., Zhou, Y., Rychahou, P., Fan, T.W., Lane, A.N., Weiss, H.L., Evers, B.M., Ketogenesis contributes to intestinal cell differentiation. Cell Death Differ. 24 (2017), 458–468.
88. Wang, B.H., Hou, Q., Lu, Y.Q., Jia, M.M., Qiu, T., Wang, X.H., Zhang, Z.X., Jiang, Y., Ketogenic diet attenuates neuronal injury via autophagy and mitochondrial pathways in pentylenetetrazol-kindled seizures. Brain Res. 1678 (2018), 106–115.
89. Weimer, S., Priebs, J., Kuhlow, D., Groth, M., Priebe, S., Mansfeld, J., Merry, T.L., Dubuis, S., Laube, B., Pfeiffer, A.F., et al. D-Glucosamine supplementation extends life span of nematodes and of ageing mice. Nat. Commun., 5, 2014, 3563.
90. Xie, Z., Zhang, D., Chung, D., Tang, Z., Huang, H., Dai, L., Qi, S., Li, J., Colak, G., Chen, Y., et al. Metabolic regulation of gene expression by histone lysine β-hydroxybutyrylation. Mol. Cell 62 (2016), 194–206.
91. Yang, Q., Zhang, Z., Gregg, E.W., Flanders, W.D., Merritt, R., Hu, F.B., Added sugar intake and cardiovascular diseases mortality among US adults. JAMA Intern. Med. 174 (2014), 516–524.
92. Youm, Y.H., Nguyen, K.Y., Grant, R.W., Goldberg, E.L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T.D., et al. The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat. Med. 21 (2015), 263–269.
93. Yubero-Serrano, E.M., Woodward, M., Poretsky, L., Vlassara, H., Striker, G.E., AGE-less Study Group. Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease. Clin. J. Am. Soc. Nephrol. 10 (2015), 759–766.
94. Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., Ben-Yacov, O., Lador, D., Avnit-Sagi, T., Lotan-Pompan, M., et al. Personalized nutrition by prediction of glycemic responses. Cell 163 (2015), 1079–1094.
95. Zelber-Sagi, S., Nitzan-Kaluski, D., Goldsmith, R., Webb, M., Blendis, L., Halpern, Z., Oren, R., Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J. Hepatol. 47 (2007), 711–717.
96. Zinman, B., Wanner, C., Lachin, J.M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O.E., Woerle, H.J., et al., EMPA-REG OUTCOME Investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N. Engl. J. Med. 373 (2015), 2117–2128.